SUDARSHAN PHARMA INDUSTRIES
Back to Cashflow Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-2.30 Cr | ₹-32 Cr | ₹7.75 Cr | ₹-29 Cr | ₹-3.82 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-2.30 Cr |
| Mar2025 | ₹-32 Cr |
| Mar2024 | ₹7.75 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹-3.82 Cr |
How is Cash Flow from Operating Activities of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2.30 Cr | Negative | |
| Mar2025 | ₹-32 Cr | Negative | |
| Mar2024 | ₹7.75 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹-3.82 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹887.7 Cr | 3.2% | -8.6% | 19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 3.2% |
-8.6% |
19.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses